[Pharmacodynamic study of a new cardiovascular drug: 4-(3',4',5'-trimethoxycinnamoyl)-1-(N-isopropylcarbamoylmethyl) piperazine maleate].
D000081:Acetamides / Q000494:pharmacology; D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002934:Cinnamates / Q000494:pharmacology*; D003326:Coronary Circulation / Q000187:drug effects; D004285:Dogs; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000633:toxicity; D014667:Vasopressins / Q000037:antagonists & inhibitors
D000081:Acetamides; D002934:Cinnamates; D010879:Piperazines; D014665:Vasodilator Agents; D014667:Vasopressins
Etude pharmacodynamique d'une nouvelle substance à activité cardiovasculaire: le maléate de (3',4',5' triméthoxy cinnamoyl)-1 (N-isopropyl amino carbonyl méthyl)-4 pipérazine